Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Juli 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020

MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
07. Juli 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar Resumes CB4211 Phase 1b Clinical Trial

MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
06. Juli 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar to Present at Sachs Novel Coronavirus Investment Forum

MENLO PARK, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
30. Juni 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering

MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
17. Juni 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar Founder Dr. Nir Barzilai’s New Book “AGE LATER” Reveals that Aging Can Be Seen as a Preventable Disease

MENLO PARK, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
02. Juni 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020

MENLO PARK, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
27. Mai 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference

MENLO PARK, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
14. Mai 2020 16:02 ET | Quelle: CohBar, Inc.

CohBar Reports First Quarter 2020 Financial Results and Provides Business Update

MENLO PARK, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
13. Mai 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role

MENLO PARK, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
05. Mai 2020 09:00 ET | Quelle: CohBar, Inc.

CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides

MENLO PARK, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...

Vorherige Seite

Nächste Seite